Prof. Motasim Badri

Prof. Motasim is a professor of Biostatistics at the Department of Epidemiology & Biostatistics at the College of Public Health & Health Informatics, King Saud bin Abdulaziz University for Health Sciences, and a Honorary Biostatistician and Senior Research Associate at the Department of Medicine of the University of Cape Town. His Bristol-Myers Squibb funded PhD was on “Studies on the Efficacy and Cost-effectiveness of therapy for HIV infection in Cape Town” in which a Markov model was developed to simulate the natural history of HIV infection and cost and cost-effectiveness implications of Combinational Antiretroviral Therapy use at the different clinical and immunologic stages of HIV infection. Some of these studies were conducted when he was a registered Visiting Postgraduate Researcher at the Department of Epidemiology and Biostatistics, McGill University, Montreal, Canada. Professor Badri taught Biostatistics and provided research consultation service at various academic and research institutions, including University of Cape Town (South Africa), Stellenbosch University (South Africa), Omdurman Islamic University (Sudan), King Saud bin Abdulaziz University for Health Sciences the Clinical Research Support Centre, Royal Victoria Hospital (Belfast, UK), The Lady Diana Princess of Wales HIV Research Centre (currently the the Desmond Tutu HIV Research Centre, Institute of Infectious Disease and Molecular Medicine, University of Cape Town). He is a founding member of the Clinical Research Support Unit at the University of Cape Town which offers research methods courses and research support consulting facilities for clinicians preparing for the Fellowship of College of Physicians of South Africa, Master of Medicine , PhD students, consultants, and international visiting fellows affiliated with Department of Medicine divisions and institutes, such as Cardiology, Neurology, Nephrology and Hypertension, Endocrinology and Diabetes Medicine, the Lung Institute, the Albertina and Walter Sisulu Institute of Aging in Africa, the Chronic Disease Initiative in Africa, the Hatter Institute for Cardiovascular Research in Africa. His consulting collaborations resulted in more than 100 highly cited peer-review publications. He is a South Africa NRF rated researcher, with h-index of 29 and RG Score of 38.35.
Birth Date


Work Experience